Sistani population: A different spectrum of β-Thalassemia mutations from other ethnic groups of Iran

Hemoglobin

Volumn 37, Issue 2, 2013, Pages 138-147

  Miri Moghaddam, Ebrahim ^a,b   Zadeh Vakili, Azita ^c   Nikravesh, Abbas ^d   Sanei Sistani, Shohreh ^b   Naroie Nejad, Mehrnaz ^a,b  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF ZABOL   (Iran)

Author keywords

Thalassemia ( thal); Iran; Mutation; Population; Prenatal diagnosis (PND)

Indexed keywords

HEMOGLOBIN BETA CHAIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BETA THALASSEMIA; CHORION VILLUS SAMPLING; CODON; CONSANGUINEOUS MARRIAGE; DNA SEQUENCE; ETHNIC GROUP; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; POPULATION; PRENATAL DIAGNOSIS; URBAN AREA;

ADOLESCENT; ADULT; ALLELES; BETA-GLOBINS; BETA-THALASSEMIA; CHILD; CODON; CONSANGUINITY; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; FEMALE; FETAL DISEASES; GENE FREQUENCY; HUMANS; INTRONS; IRAN; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84874867098     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2013.769886     Document Type: Article

References (34)

1. Weatherall DJ, Clegg JB, Eds. The Thalassaemia Syndromes, 4th ed. Oxford: Blackwell Science, 2001.
2. Rahimi Z, Muniz A, Parsian A. Detection of responsible mutations for β-thalassemia in the Kermanshah Province of Iran using PCR-based techniques. Mol Biol Rep. 2010;37(1):149-154.
3. Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001;25(3):285-296.
4. Cao A, Galanello R. β-Thalassemia. Genet Med. 2010;12(2):61-76.
5. Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, et al. Distribution of β-thalassemia mutations in the northern provinces of Iran. Hemoglobin. 2007;31(3):351-356.
6. Eshghi P, Zadeh-Vakili A, Rashidi A, Miri-Moghaddam E. An unusually frequent β-thalassemia mutation in an Iranian Province. Hemoglobin. 2008;32(4):387-392.
7. Haghi M, Khorshidi S, Hosseinpour Feizi MA, Pouladi N, Hosseinpour Feizi AA. β-Thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces. Hemoglobin. 2009;33(2):109-114.
8. Hosseinpour Feizi MA, Hosseinpour Feizi AA, Pouladi N, Haghi M, Azarfam P. Molecular spectrum of β-thalassemia mutations in Northwestern Iran. Hemoglobin. 2008;32(3):255-261.
9. Merat A, Haghshenas M, Pour ZM, et al. β-Thalassemia in southwestern Iran. Hemoglobin. 1993;17(5):427-437.
10. Najmabadi H, Pourfathollah AA, Neishabury M, Sahebjam F, Krugluger W, Oberkanins C. Rare and unexpected mutations among Iranian β-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica. 2002;87(10):1113-1114.
11. Nikuei P, Hadavi V, Rajaei M, Saberi M, Hajizade F, Najmabadi H. Prenatal diagnosis for β-thalassemia major in the Iranian Province of Hormozgan. Hemoglobin. 2008;32(6):539-545.
12. Noori-Daloii MR, Moazami N, Farhangi S, et al. β-Thalassemia in Iran: a high incidence of the nonsense codon 39 mutation on the island of Queshm. Hemoglobin. 1994;18(6):449-453.
13. Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin. 2001;25(1):35-43.
14. Miri-Moghaddam E, Zadeh-Vakili A, Rouhani Z, Naderi M, Eshghi P, Khazaei Feizabad A. Molecular basis and prenatal diagnosis of β-thalassemia among Balouch population in Iran. Prenat Diagn. 2011;31(8):788-791.
15. Ghotbi N, Tsukatani T. Evaluation of national health policy of thalassemia screening in the Islamic Republic of Iran. East Mediterr Health J. 2005;11(3):308-318.
16. Cao A, Rosatelli MC, Monni G, Galanello R. Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am. 2002;29(2):305-328.
17. Rosatelli MC, Saba L. Prenatal diagnosis of β-thalassemia and hemoglobinopathies. Mediterr J Hematol Infect Dis. 2009;1(1):e2009011.
18. Fallah MS, Samavat A, Zeinali S. Iranian national program for the prevention of thalassemia and prenatal diagnosis: mandatory premarital screening and legal medical abortion. Prenat Diagn. 2009;29 (13):1285-1286.
19. Stephens AD, Angastiniotis M, Baysal E, et al. International Council for the Standardization of Hematology (ICSH) recommendations for the measurement of Haemoglobin A2. Int J Lab Hematol. 2012;34(1):1-13.
20. Sambrook J, Russell DW, Eds. Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2001.
21. Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003;17(1):43-53.
22. Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of β-thalassaemia deletions and α-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108(2):295-299.
23. Thein SL, Hesketh C, Brown JM, Anstey AV, Weatherall DJ. Molecular characterization of a high A2 α thalassemia by direct sequencing of single strand enriched amplified genomic DNA. Blood 1989;73 (4):924-930.
24. Harteveld CL, Voskamp A, Phylipsen M, et al. Nine unknown rearrangements in 16p 13.3 and 11 p 15.4 causing α- and β-thalassemia characterized by high resolution multiplex ligation dependent probe amplification. J Med Genet. 2005;42(12):922-931.
25. Old JM, Petrou M, Modell B, Weatherall DJ. Feasibility of antenatal diagnosis of β-thalassaemia by DNA polymorphisms in Asian Indian and Cypriot populations. Br J Haematol. 1984;57(2):255-263.
26. Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007;29(4):233-238.
27. Derakhshandeh-Peykar P, Hourfar H, Heidari M, Kheirollahi M, Miryounesi M. The spectrum of β-thalassemia mutations in Isfahan Province of Iran. Iranian J Publ Health. 2008;37(2):106-111.
28. Colah R, Gorakshakar A, Nadkarni A, et al. Regional heterogeneity of β-thalassemia mutations in the multi ethnic Indian population. Blood Cells Mol Dis. 2009;42(3):241-246.
29. Ahmed S. Prenatal diagnosis of β-thalassemia: 12 years' experience at a single laboratory in Pakistan. Prenat Diagn. 2007;27(13):1224-1227.
30. Quaife R, al-Gazali L, Abbes S, et al. The spectrum of α thalassaemia mutations in the UAE national population. J Med Genet. 1994;31(1):59-61.
31. Daar S, Hussein HM, Merghoub T, Krishnamoorthy R. Spectrum of β-thalassemia mutations in Oman. Ann NY Acad Sci. 1998;850:404-406.
32. Saleh-Gohari N, Bazrafshani M. Distribution of α-globin gene mutations in thalassemia minor population of Kerman Province, Iran. Iranian J Publ Health. 2010;39(2):69-76.
33. Rahim F, Ahadi R. Thalassemia and haemoglobin disorders in the Khuzestan province of Iran. J Clin Diagn Res. 2008;3(3):820-826.
34. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003;101(6):2137-2143.